1. Home
  2. INVZ vs OBIO Comparison

INVZ vs OBIO Comparison

Compare INVZ & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • OBIO
  • Stock Information
  • Founded
  • INVZ 2016
  • OBIO 2017
  • Country
  • INVZ Israel
  • OBIO United States
  • Employees
  • INVZ N/A
  • OBIO N/A
  • Industry
  • INVZ Auto Parts:O.E.M.
  • OBIO Medicinal Chemicals and Botanical Products
  • Sector
  • INVZ Consumer Discretionary
  • OBIO Health Care
  • Exchange
  • INVZ Nasdaq
  • OBIO Nasdaq
  • Market Cap
  • INVZ 154.6M
  • OBIO 151.3M
  • IPO Year
  • INVZ N/A
  • OBIO N/A
  • Fundamental
  • Price
  • INVZ $0.52
  • OBIO $2.71
  • Analyst Decision
  • INVZ Strong Buy
  • OBIO Strong Buy
  • Analyst Count
  • INVZ 5
  • OBIO 5
  • Target Price
  • INVZ $3.24
  • OBIO $15.40
  • AVG Volume (30 Days)
  • INVZ 3.3M
  • OBIO 58.7K
  • Earning Date
  • INVZ 05-07-2025
  • OBIO 05-12-2025
  • Dividend Yield
  • INVZ N/A
  • OBIO N/A
  • EPS Growth
  • INVZ N/A
  • OBIO N/A
  • EPS
  • INVZ N/A
  • OBIO N/A
  • Revenue
  • INVZ $24,268,000.00
  • OBIO $2,638,000.00
  • Revenue This Year
  • INVZ $135.37
  • OBIO $54.21
  • Revenue Next Year
  • INVZ $132.60
  • OBIO $3.37
  • P/E Ratio
  • INVZ N/A
  • OBIO N/A
  • Revenue Growth
  • INVZ 16.25
  • OBIO N/A
  • 52 Week Low
  • INVZ $0.45
  • OBIO $3.07
  • 52 Week High
  • INVZ $3.14
  • OBIO $8.87
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 26.77
  • OBIO 30.71
  • Support Level
  • INVZ $0.59
  • OBIO $4.14
  • Resistance Level
  • INVZ $0.76
  • OBIO $4.67
  • Average True Range (ATR)
  • INVZ 0.04
  • OBIO 0.41
  • MACD
  • INVZ 0.01
  • OBIO -0.11
  • Stochastic Oscillator
  • INVZ 3.67
  • OBIO 3.73

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: